Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of AVZO-021 in Patients With Advanced Solid TumorsAdnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, carcinoma, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, primary peritoneal carcinoma, skin disorder, triple-negative breast carcinoma, uterine disorderRecruitingPhase 1 / Phase 22026-09-28NCT05867251

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Avenzo Therapeutics, Inc.4

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Avenzo Therapeutics Recruiting SiteSarasotaUnited States3
Avenzo Therapeutics Recruiting SiteNew HavenUnited States1
Avenzo Therapeutics Recruiting SiteTampaUnited States4
Avenzo Therapeutics Recruiting SiteNew YorkUnited States2
Avenzo Therapeutics Recruiting SiteWollongongAustralia1
Avenzo Therapeutics Recruiting SiteFairfaxUnited States3
Avenzo Therapeutics Recruiting SiteOklahoma CityUnited States1
Avenzo Therapeutics Recruiting SiteClevelandUnited States3
Avenzo Therapeutics Recruiting SiteMineolaUnited States1
Avenzo Therapeutics Recruiting SiteDallasUnited States1
Avenzo Therapeutics Recruiting SitePortlandUnited States1
Avenzo Therapeutics Recruiting SitePhiladelphiaUnited States2
Avenzo Therapeutics Recruiting SiteMacquarie UniversityAustralia1